Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Receivables (2016 - 2025)

Healthstream (HSTM) has disclosed Change in Receivables for 16 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 19.23% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, up 841.71% year-over-year, with the annual reading at $4.0 million for FY2025, 841.71% up from the prior year.
  • Change in Receivables for Q4 2025 was $5.0 million at Healthstream, up from $2.4 million in the prior quarter.
  • The five-year high for Change in Receivables was $10.0 million in Q4 2022, with the low at -$7.4 million in Q1 2021.
  • Average Change in Receivables over 5 years is -$118550.0, with a median of -$329500.0 recorded in 2021.
  • The sharpest move saw Change in Receivables tumbled 498.03% in 2021, then soared 181.87% in 2022.
  • Over 5 years, Change in Receivables stood at $3.6 million in 2021, then surged by 181.87% to $10.0 million in 2022, then plummeted by 60.3% to $4.0 million in 2023, then increased by 5.52% to $4.2 million in 2024, then grew by 19.23% to $5.0 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $5.0 million, $2.4 million, and -$4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.